HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takeuchi, O. Articles by Akira, S. Search for Related Content PubMed PubMed Citation Articles by Takeuchi, O. Articles by Akira, S.

Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway¹

Osamu Takeuchi^*,, Andreas Kaufmann, Karsten Grote, Taro Kawai^*,, Katsuaki Hoshino^*,, Michael Morr, Peter F. Mühlradt^2, and Shizuo Akira^2,3,*,

^* Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation, Osaka, Japan; Institute of Immunology, Philipps University, Marburg, Germany; and Immunobiology Research Group, Gesellschaft für Biotechnologische Forschung, Braunschweig, Germany

	Abstract

Top Abstract Introduction Materials and Methods Results and Discussion References

 
Mycoplasmas and their membranes are potent activators of macrophages, the active principle being lipoproteins and lipopeptides. Two stereoisomers of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 (MALP-2) differing in the configuration of the lipid moiety were synthesized and compared in their macrophage-activating potential, the R-MALP being >100 times more active than the S-MALP in stimulating the release of cytokines, chemokines, and NO. To assess the role of the Toll-like receptor (TLR) family in mycoplasmal lipopeptide signaling, the MALP-2-mediated responses were analyzed using macrophages from wild-type, TLR2-, TLR4-, and MyD88-deficient mice. TLR2- and MyD88-deficient cells showed severely impaired cytokine productions in response to R- and S-MALP. The MALP-induced activation of intracellular signaling molecules was fully dependent on both TLR2 and MyD88. There was a strong preference for the R-MALP in the recognition by its functional receptor, TLR2.

	Introduction

Top Abstract Introduction Materials and Methods Results and Discussion References

 
Mycoplasmas are wall-less bacteria that occur as commensals or pathogens in animals and humans (1). Being wall-less, mycoplasmas lack the classical modulins such as LPS, lipoteichoic acid (LTA),⁴ or murein fragments (reviewed in Ref. 2), yet they are potent activators of macrophages (3). A number of independent reports have identified this macrophage-activating material as lipoproteins (4, 5, 6) or lipopeptides (7, 8). One of these lipopeptides, the 2-kDa macrophage-activating lipopeptide-2 (MALP-2) from Mycoplasma fermentans, was biochemically fully characterized and has become available by synthesis (7). The lipid moiety has an asymmetric C atom at the 2 position. The formerly used synthetic MALP-2 was the S, R racemate and had a similar sp. act. as the natural compound acting at picomolar concentrations in vitro (7, 9, 10).

Little is known about the signal pathways or the cell-surface receptors for MALP-2, except that MALP-2 activates the nuclear transcription factor NF-B (11, 12). A new class of receptors of the innate immune system, the so-called Toll-like receptors (TLRs), was recently discovered (13, 14, 15), which recognize various bacterial cell-wall components such as LPS, peptidoglycan (PGN), LTA, and lipoproteins/lipopeptides (16, 17, 18, 19, 20, 21, 22). Overexpression of human TLR2 conferred responsiveness to various kinds of bacterial components (16, 17, 19, 20, 21, 22). To investigate the in vivo roles of the TLR family in the recognition of bacterial components, we have generated TLR2-deficient and TLR4-deficient mice. A mutation in the TLR4 gene is responsible for the LPS hyporesponsiveness of C3H/HeJ mouse strain (18), and the deficiency results in lack of responsiveness to LPS and LTA (23, 24). In contrast, TLR2-deficient mice show impaired responsiveness to PGN, but normal responses to LPS (24). These observations indicate different respective specificities of TLR2 and TLR4 in the recognition of bacterial components. The TLR family, whose cytoplasmic domain is homologous to that of IL-1R, has been shown to interact with an adapter molecule, MyD88, for the activation of IL-1R-associated kinase (IRAK) (25). Ultimately, NF-B translocates from the cytoplasm to the nucleus and activates genes with NF-B binding sites in their promoters. We have previously shown that MyD88-deficient mice are unresponsive to LPS, IL-1, and IL-18 (26, 27).

To assess the role of TLR family and MyD88 in mycoplasmal lipopeptide signaling, we analyzed MALP-2-mediated responses using two steroisomers of MALP-2 and macrophages from TLR2-, TLR4-, and MyD88-deficient mice. We will show that there is a stringent requirement of the correct stereochemistry in the lipid moiety for the recognition of MALP by its functional receptor. We will further show that this receptor is TLR2, which transfers its signal via MyD88.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results and Discussion References

 
Stereospecific synthesis and HPLC purification of R- and S-MALP-2

The stereoisomers of S-(2,3-dihydroxypropyl)-L-cystein were synthesized as outlined by Metzger et al. (28) using (S)-(-)-glycidol and (R)-(+)-glycidol, respectively, obtained from Sigma-Aldrich (St. Louis, MO), as starting materials. According to the supplier, these reagents contained >99% of the respective pure enantiomers. The N-fluorenylmethoxycarbonyl-protected S-(2(S),3 bis(palmitoyloxy)propyl]-L-cystein or S-(2(R),3-bis(palmitoyloxy)propyl]-L-cystein isomers, respectively, were synthesized and coupled to the carrier-bound fluorenylmethoxycarbonyl-protected peptide as described (28). It is important to point out that, although the configuration of the asymmetric carbon atom of the glycidol remains the same during this procedure, its designation changes from S to R and vice versa because of the Cahn Ingold-Prelog rules of assigning priorities to substituents according to their atomic mass. Crude MALP-2 was further purified in 10-mg batches by reversed phase HPLC on a SP 250/10 Nucleosil 300-7 C8 column (Macherey & Nagel, Düren, Germany) and was eluted at 40°C with a linear water/2-propanol gradient containing 0.1% TFA. Elution of active material was monitored by the NO release assay (7). The final product was characterized by mass spectroscopy and amino acid analysis by which also the exact peptide content was determined. MALP-2 was kept as a stock solution of 1 mg/ml in water/2-propanol 1/1 (v/v) at 4°C. For in vitro use, stock solutions were first diluted with 25 mM octyl glucoside in saline to provide a carrier and optimal solubilization and were then further diluted with culture medium. The maximal final detergent concentration in these studies was adjusted to 25 µM in all cultures and had no effects on the cells.

Mice

C3H/HeJ endotoxin low-responder mice were from The Jackson Laboratory (Bar Harbor, ME). The mutant mouse (F₂ interbred from 129/Ola x C57BL/6) strains deficient in TLR2, TLR4, or MyD88 were generated by gene targeting as described previously (23, 24, 26). Age-matched groups of wild-type, TLR2-, TLR4-, and MyD88-deficient mice were used for the experiments.

Cell culture and macrophage/monocyte stimulation assays

Adherent cells from either resident peritoneal exudate cell (PEC) from C3H/HeJ endotoxin low-responder mice or from thioglycollate-elicited PEC from the 129/Ola x C57BL/6 wild-type or mutant strains were used as source of murine macrophages. Nonadherent cells were removed, and fresh medium, DMEM, 5% FCS, 2.5 x 10^-5 M 2-ME, with or without stimulants were added. Human monocytes from healthy volunteers were prepared by elutriation and stimulated as described (10). Samples for assaying cytokines, chemokines, or NO were removed after the indicated times. TNF- was tested in a cytotoxicity assay as described (9) or by ELISA (Genzyme, Cambridge, MA), IL-6 was determined in a capture ELISA (9). NO release was assayed as described (7) or using an NO₂/NO₃ assay Kit-C (Dojindo, Kumamoto, Japan). Concentrations of IL-8 and monocyte chemoattractant protein-1 were measured by ELISA as described previously (10).

In vitro kinase assay and Western blotting

Peritoneal macrophages (1 x 10⁶) were stimulated with 0.3 ng/ml of R-MALP for 10 min. The cells were lysed with lysis buffer and immunoprecipitated with anti-IRAK Ab. The IRAK activity was measured by in vitro kinase assay as described previously (27). Anti-IRAK Ab was kindly provided by Hayashibara Biochemical Laboratories (Okayama, Japan). For determination of c-Jun N-terminal kinase (JNK) activity, cell lysates were immunoprecipitated with anti-JNK1 Ab, and the in vitro kinase assay was performed using GST-c-Jun as substrate as described previously (27). The cell lysates were applied to SDS-PAGE and transferred to a nitrocellulose membrane. IRAK and JNK were detected with anti-IRAK (Transduction Laboratories, Lexington, KY) or anti-JNK1 Ab.

EMSA

Peritoneal macrophages (2 x 10⁶) were stimulated with 0.3 ng/ml of R-MALP for the indicated periods. Nuclear extracts were prepared from these cells and incubated with a ³²P-labeled specific probe for NF-B DNA binding site. Samples were electrophoresed and visualized by autoradiography as described previously (26).

	Results and Discussion

Top Abstract Introduction Materials and Methods Results and Discussion References

 
Biological activity of MALP-2 depends on the stereochemistry of the lipid moiety

Natural MALP-2 isolated from a high-producer clone of M. fermentans shows a similar sp. act. as that of racemic synthetic MALP-2 (7). If we assume that the biosynthesis of mycoplasmal lipoproteins in principle proceeds like in Escherichia coli (29), the entire lipid moiety from phosphatidylglycerol is transferred to the prolipoprotein. Natural phosphatidylglycerol has the S configuration at the 2 position of the fatty acid-substituted glycerol. Because according to the Cahn-Ingold-Prelog rules the assignment of substituents of an asymmetric atom depends on the atomic mass of the neighboring substituents, the designation changes from S to R when the lipid moiety is transferred to the lipoprotein. Therefore, natural MALP-2 is expected to have the R configuration. A comparison of the biological activities of R- and S-MALP-2 indeed shows that R-MALP exhibits a much higher sp. act. than its S counterpart. This appears to be valid for murine as well as human MALP-2-reactive cells (Figs. 1 and 2). In fact, a contamination of S-MALP with the R isomer resulting from <1% impurity of the starting material would explain the remaining activity of the S-MALP-2, which in its pure form may be quite inactive. The data suggest that a putative MALP-2 receptor is capable to specifically recognize the configuration of the lipid moiety and to discriminate between the R and S stereoisomers. This is in keeping with previous observations that the peptide moiety, as long as solubility is ensured, is of little if any consequence for the macrophage stimulatory activity of lipopeptides (see also Ref. 8).

View larger version (22K): [in this window] [in a new window]   FIGURE 1. C3H/HeJ macrophages show a different dose response to R- and S-MALP stereoisomers. A total of 6 x 105 PEC were seeded in 1.25 ml DMEM, 5% FCS, 2.5 x 10-5 M 2-ME into 24-well cell culture plates, and macrophages were allowed to adhere during an overnight incubation. Nonadherent cells were removed and fresh medium with or without stimulants were added. The cultures were simultaneously stimulated with rIFN- to determine the release of TNF-, IL-6, and NO from identical cultures. Samples for assaying cytokines, chemokines, or NO were removed after 3, 21, or 46 h, respectively. Results represent values from duplicate cultures ± SD.

To identify a putative cell-surface receptor responsible for the signaling of MALP-2, we examined the responsiveness of peritoneal macrophages from wild-type, TLR2-, TLR4-, and MyD88-deficient mice to R-MALP and S-MALP. Peritoneal macrophages from wild-type and TLR4-deficient mice produced comparable amount of TNF- or NO in a dose-dependent manner. In contrast, macrophages from TLR2- and MyD88-deficient mice produced neither TNF- nor NO (Fig. 3, A and B). Similar results were obtained using S-MALP as the stimulants, although much higher doses were required (Fig. 3, C and D). IL-6 production in response to R- and S-MALP was also abrogated in TLR2- and MyD88-deficient macrophages (data not shown). These results clearly demonstrate that a TLR2-dependent signaling pathway is essential for the cellular responses to mycoplasmal lipoproteins/lipopeptides, exemplified by R-MALP-2.

View larger version (33K): [in this window] [in a new window]   FIGURE 3. TLR2- and MyD88-deficient mice are unresponsive to both R- and S-MALP. Peritoneal macrophages from wild-type, TLR2-, TLR4-, and MyD88-deficient mice were cultured with the indicated amount of R-MALP (A and B) or S-MALP (C and D) in presence (B and D) or absence (A and B) of IFN- (30 U/ml) for 24 h. Concentrations of TNF- (A and C) and NO (B and D) in the culture supernatants were measured by ELISA.

We next examined the downstream signaling pathway of MALP-2. Triggering of the TLR/IL-1R family signaling cascade requires the recruitment of MyD88 to the receptor complex, which then activates NF-B and JNK, via IRAK (25, 27). As shown in Fig. 3, A and B, cytokine productions from MyD88-deficient macrophages were severely impaired compared with those from wild-type macrophages. We then analyzed the kinase activity of IRAK by an in vitro kinase assay using these mutant macrophages. Autophosphorylation of IRAK was observed in wild-type and TLR4-deficient macrophages after the treatment with R-MALP. In contrast, IRAK activation was abrogated in TLR2- and MyD88-deficient macrophages (Fig. 4A). We further examined the MALP-2-induced NF-B activation. In wild-type and TLR4-deficient macrophages, NF-B was activated within 20 min of MALP treatment. In contrast, no NF-B activation was detected in TLR2- or MyD88-deficient macrophages (Fig. 4B). Finally, we determined whether or not MALP-induced JNK activation was also TLR2- and MyD88-dependent. As shown in Fig. 4C, JNK was activated in wild-type and TLR4-deficient macrophages. Again in TLR2- or MyD88-deficient macrophages no JNK activation was observed.

View larger version (63K): [in this window] [in a new window]   FIGURE 4. R-MALP-induced activation of IRAK, NF-B, and JNK is abrogated in TLR2- and MyD88-deficient macrophages. A, Peritoneal macrophages were stimulated with 0.3 ng/ml of R-MALP for 10 min. Then cells were lysed and immunoprecipitated with anti-IRAK-1 Ab. IRAK activity was determined by in vitro kinase assay (upper panel). The same lysates were immunoblotted with anti-IRAK Ab (lower panel). B, Peritoneal macrophages were exposed with 0.3 ng/ml of R-MALP for indicated periods. The nuclear extracts were prepared and incubated with a radiolabeled specific probe containing NF-B binding site. NF-B activation was analyzed by EMSA. An arrow indicates induced NF-B complex. Free probes are indicated by an arrowhead. C, Peritoneal macrophages were stimulated with 0.3 ng/ml of R-MALP for indicated periods. Then cell lysates were prepared and immunoprecipitated with anti-JNK1 Ab. The kinase activity of JNK was measured by in vitro kinase assay using GST-c-Jun as the substrate. Auto, Autophosphorylation. WB, Western blotting.

View larger version (21K): [in this window] [in a new window]   FIGURE 2. Human monocytes show a different dose response to R- and S-MALP stereoisomers. A total of 7.5 x 105 elutriated human monocytes were stimulated for 20 h with the indicated concentrations of the MALP stereoisomers. Cytokine and chemokine levels were determined by specific ELISAs. Results represent values from duplicate cultures ± SD.

	Acknowledgments

	Footnotes

 
¹ This work was supported by grants from the Ministry of Education of Japan and by the Deutsche Forschungsgemeinschaft (Mu672/2-3 and SP395/2-2).

² P.F.M. and S.A. contributed equally to this work.

³ Address correspondence and reprint requests to Dr. Shizuo Akira, Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan. E-mail address:

⁴ Abbreviations used in this paper: LTA, lipoteichoic acid; TLR, Toll-like receptor; MALP, macrophage-activating lipopeptide; PGN, peptidoglycan; IRAK, IL-1R-associated kinase; JNK, c-Jun N-terminal kinase

Received for publication October 14, 1999. Accepted for publication November 11, 1999.

	References

Top Abstract Introduction Materials and Methods Results and Discussion References

 

1. Baseman, J. B., J. G. Tully. 1997. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg. Infect. Dis. 3:21.[Medline]
2. Henderson, B., S. Poole, M. Wilson. 1996. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60:316.[Abstract/Free Full Text]
3. Mühlradt, P. F., H. Quentmeier, E. Schmitt. 1991. Involvement of interleukin-1 (IL-1), IL-6, IL-2, and IL-4 in generation of cytolytic T cells from thymocytes stimulated by a Mycoplasma fermentans-derived product. Infect. Immun. 59:3962.[Abstract/Free Full Text]
4. Feng, S.-H., S.-C. Lo. 1994. Induced mouse spleen B-cell proliferation and secretion of immunoglobulin by lipid-associated membrane proteins of Mycoplasma fermentans incognitus and Mycoplasma penetrans. Infect. Immun. 62:3916.[Abstract/Free Full Text]
5. Herbelin, A., E. Ruuth, D. Delorme, C. Michel-Herbelin, F. Praz. 1994. Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor by human monocytes. Infect. Immun. 62:4690.[Abstract/Free Full Text]
6. Kostyal, D. A., G. H. Butler, D. H. Beezhold. 1994. A 48-kilodalton Mycoplasma fermentans membrane protein induces cytokine secretion by human monocytes. Infect. Immun. 62:3793.[Abstract/Free Full Text]
7. Mühlradt, P. F., M. Kie, H. Meyer, R. Sümuth, G. Jung. 1997. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185:1951.[Abstract/Free Full Text]
8. Mühlradt, P.F., M. Kie, H. Meyer, R. Sümuth, G. Jung. 1998. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis. Infect. Immun. 66:4804.[Abstract/Free Full Text]
9. Deiters, U., P. F. Mühlradt. 1999. Mycoplasmal lipopeptide MALP-2 induces the chemoattractant proteins MIP-1, MCP-1 and MIP-2 and promotes leukocyte infiltration in mice. Infect. Immun. 67:3390.[Abstract/Free Full Text]
10. Kaufmann, A., P. F. Mühlradt, D. Gemsa, H. Sprenger. 1999. Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2. Infect. Immun. 67:6303.[Abstract/Free Full Text]
11. Sacht, G., A. Märten, U. Deiters, R. Sümuth, G. Jung, E. Wingender, P. F. Mühlradt. 1998. Activation of nuclear factor-B in macrophages by mycoplasmal lipopeptides. Eur. J. Immunol. 28:4207.[Medline]
12. Garcia, J., B. Lemercier, S. Roman-Roman, G. Rawadi. 1998. A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF B activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways. J. Biol. Chem. 273:34391.[Abstract/Free Full Text]
13. Medzhitov, R., P. Preston-Hurburt, Jr C. A. Janeway. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394.[Medline]
14. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588.[Abstract/Free Full Text]
15. Takeuchi, O., T. Kawai, H. Sanjo, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, K. Takeda, S. Akira. 1999. TLR6: A novel member of an expanding Toll-like receptor family. Gene 231:59.[Medline]
16. Yang, B. R., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, P. J. Godowski. 1998. Toll-like receptor-2 mediated lipoplysaccharide-induced cellular signalling. Nature 395:284.[Medline]
17. Kirschning, C. J., H. Wesche, T. Merrill Ayres, M. Rothe. 1998. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:2091.[Abstract/Free Full Text]
18. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.[Abstract/Free Full Text]
19. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406.[Abstract/Free Full Text]
20. Brightbill, D. H., H. D. Libraty, R. S. Krutzik, B. R. Yang, T. J. Belisle, R. J. Bleharski, M. Maitland, V. M. Norgard, E. S. Plevy, T. S. Smale, et al 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732.[Abstract/Free Full Text]
21. Aliprantis, O. A., R. B. Yang, R. M. Mark, S. Suggett, B. Devaux, D. J. Radolf, R. G. Klimpel, P. Godowski, A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736.[Abstract/Free Full Text]
22. Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten, J. J. Weis. 1999. Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163:2382.[Abstract/Free Full Text]
23. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, S. Akira. 1999. TLR4-deficient mice are hyporesponsive to LPS: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749.[Abstract/Free Full Text]
24. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, T. Ogawa, H. Takada, K. Takeda, S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443.[Medline]
25. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, Jr C. A. Janeway. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2:253.[Medline]
26. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143.[Medline]
27. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115.[Medline]
28. Metzger, J.W., K.-H. Wiesmüller, G. Jung. 1991. Synthesis of N-Fmoc protected derivatives of S-(2,3-dihydroxypropyl)-cysteine and their application in peptide synthesis. Int. J. Peptide Protein Res. 38:545.[Medline]
29. Sankaran, K., H. C. Wu. 1994. Lipid modification of bacterial prolipoprotein. J. Biol.Chem. 269:19701.[Abstract/Free Full Text]

This article has been cited by other articles:

				J.-E. Park, Y.-I. Kim, and A.-K. Yi Protein Kinase D1 Is Essential for MyD88-Dependent TLR Signaling Pathway J. Immunol., May 15, 2009; 182(10): 6316 - 6327. [Abstract] [Full Text] [PDF]

				Y. Wan, H. Xiao, J. Affolter, T. W. Kim, K. Bulek, S. Chaudhuri, D. Carlson, T. Hamilton, B. Mazumder, G. R. Stark, et al. Interleukin-1 Receptor-associated Kinase 2 Is Critical for Lipopolysaccharide-mediated Post-transcriptional Control J. Biol. Chem., April 17, 2009; 284(16): 10367 - 10375. [Abstract] [Full Text] [PDF]

				K. Reppe, T. Tschernig, A. Luhrmann, V. van Laak, K. Grote, M. V. Zemlin, B. Gutbier, H. C. Muller, M. Kursar, H. Schutte, et al. Immunostimulation with Macrophage-Activating Lipopeptide-2 Increased Survival in Murine Pneumonia Am. J. Respir. Cell Mol. Biol., April 1, 2009; 40(4): 474 - 481. [Abstract] [Full Text] [PDF]

				L. M. Gargano, J. C. Forrest, and S. H. Speck Signaling through Toll-Like Receptors Induces Murine Gammaherpesvirus 68 Reactivation In Vivo J. Virol., February 1, 2009; 83(3): 1474 - 1482. [Abstract] [Full Text] [PDF]

				A. L. F. Bernardino, T. A. Myers, X. Alvarez, A. Hasegawa, and M. T. Philipp Toll-Like Receptors: Insights into Their Possible Role in the Pathogenesis of Lyme Neuroborreliosis Infect. Immun., October 1, 2008; 76(10): 4385 - 4395. [Abstract] [Full Text] [PDF]

				T. Shimizu, Y. Kida, and K. Kuwano A Triacylated Lipoprotein from Mycoplasma genitalium Activates NF-{kappa}B through Toll-Like Receptor 1 (TLR1) and TLR2 Infect. Immun., August 1, 2008; 76(8): 3672 - 3678. [Abstract] [Full Text] [PDF]

				T. Shimizu, Y. Kida, and K. Kuwano Ureaplasma parvum lipoproteins, including MB antigen, activate NF-{kappa}B through TLR1, TLR2 and TLR6 Microbiology, May 1, 2008; 154(5): 1318 - 1325. [Abstract] [Full Text] [PDF]

				V. M. Abrahams, P. B. Aldo, S. P. Murphy, I. Visintin, K. Koga, G. Wilson, R. Romero, S. Sharma, and G. Mor TLR6 Modulates First Trimester Trophoblast Responses to Peptidoglycan J. Immunol., May 1, 2008; 180(9): 6035 - 6043. [Abstract] [Full Text] [PDF]

				W. Piao, C. Song, H. Chen, L. M. Wahl, K. A. Fitzgerald, L. A. O'Neill, and A. E. Medvedev Tyrosine Phosphorylation of MyD88 Adapter-like (Mal) Is Critical for Signal Transduction and Blocked in Endotoxin Tolerance J. Biol. Chem., February 8, 2008; 283(6): 3109 - 3119. [Abstract] [Full Text] [PDF]

				T. Shimizu, Y. Kida, and K. Kuwano Mycoplasma pneumoniae-Derived Lipopeptides Induce Acute Inflammatory Responses in the Lungs of Mice Infect. Immun., January 1, 2008; 76(1): 270 - 277. [Abstract] [Full Text] [PDF]

				T. R. Murphy, H. J. Legere III, and H. R. Katz Activation of Protein Kinase D1 in Mast Cells in Response to Innate, Adaptive, and Growth Factor Signals J. Immunol., December 1, 2007; 179(11): 7876 - 7882. [Abstract] [Full Text] [PDF]

				L. Neff, S. Daher, P. Muzzin, U. Spenato, F. Gulacar, C. Gabay, and S. Bas Molecular Characterization and Subcellular Localization of Macrophage Infectivity Potentiator, a Chlamydia trachomatis Lipoprotein J. Bacteriol., July 1, 2007; 189(13): 4739 - 4748. [Abstract] [Full Text] [PDF]

				A. Greis, J. Murgott, S. Rafalzik, R. Gerstberger, T. Hubschle, and J. Roth Characterization of the febrile response induced by fibroblast-stimulating lipopeptide-1 in guinea pigs Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R152 - R161. [Abstract] [Full Text] [PDF]

				A. E. Medvedev, W. Piao, J. Shoenfelt, S. H. Rhee, H. Chen, S. Basu, L. M. Wahl, M. J. Fenton, and S. N. Vogel Role of TLR4 Tyrosine Phosphorylation in Signal Transduction and Endotoxin Tolerance J. Biol. Chem., June 1, 2007; 282(22): 16042 - 16053. [Abstract] [Full Text] [PDF]

				T. W. Kim, K. Staschke, K. Bulek, J. Yao, K. Peters, K.-H. Oh, Y. Vandenburg, H. Xiao, W. Qian, T. Hamilton, et al. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity J. Exp. Med., May 14, 2007; 204(5): 1025 - 1036. [Abstract] [Full Text] [PDF]

				T. Kawagoe, S. Sato, A. Jung, M. Yamamoto, K. Matsui, H. Kato, S. Uematsu, O. Takeuchi, and S. Akira Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling J. Exp. Med., May 14, 2007; 204(5): 1013 - 1024. [Abstract] [Full Text] [PDF]

				T. Into, J.-i. Dohkan, M. Inomata, M. Nakashima, K.-i. Shibata, and K. Matsushita Synthesis and Characterization of a Dipalmitoylated Lipopeptide Derived from Paralogous Lipoproteins of Mycoplasma pneumoniae Infect. Immun., May 1, 2007; 75(5): 2253 - 2259. [Abstract] [Full Text] [PDF]

				D. D. Bolz, R. S. Sundsbak, Y. Ma, S. Akira, J. H. Weis, T. G. Schwan, and J. J. Weis Dual Role of MyD88 in Rapid Clearance of Relapsing Fever Borrelia spp. Infect. Immun., December 1, 2006; 74(12): 6750 - 6760. [Abstract] [Full Text] [PDF]

				Y. F. Lau, G. Deliyannis, W. Zeng, A. Mansell, D. C. Jackson, and L. E. Brown Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines Int. Immunol., December 1, 2006; 18(12): 1801 - 1813. [Abstract] [Full Text] [PDF]

				A. Riccioli, D. Starace, R. Galli, A. Fuso, S. Scarpa, F. Palombi, P. De Cesaris, E. Ziparo, and A. Filippini Sertoli Cells Initiate Testicular Innate Immune Responses through TLR Activation J. Immunol., November 15, 2006; 177(10): 7122 - 7130. [Abstract] [Full Text] [PDF]

				R. S. Kornbluth and G. W. Stone Immunostimulatory combinations: designing the next generation of vaccine adjuvants J. Leukoc. Biol., November 1, 2006; 80(5): 1084 - 1102. [Abstract] [Full Text] [PDF]

				H. Negishi, Y. Fujita, H. Yanai, S. Sakaguchi, X. Ouyang, M. Shinohara, H. Takayanagi, Y. Ohba, T. Taniguchi, and K. Honda Evidence for licensing of IFN-{gamma}-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program PNAS, October 10, 2006; 103(41): 15136 - 15141. [Abstract] [Full Text] [PDF]

				J. M. Buckley, J. H. Wang, and H. P. Redmond Cellular reprogramming by gram-positive bacterial components: a review J. Leukoc. Biol., October 1, 2006; 80(4): 731 - 741. [Abstract] [Full Text] [PDF]

				A. Hasebe, N. D. Pennock, H.-H. Mu, F. V. Chan, M. L. Taylor, and B. C. Cole A Microbial TLR2 Agonist Imparts Macrophage-Activating Ability to Apolipoprotein A-1 J. Immunol., October 1, 2006; 177(7): 4826 - 4832. [Abstract] [Full Text] [PDF]

				M. Dubourdeau, R. Athman, V. Balloy, M. Huerre, M. Chignard, D. J. Philpott, J.-P. Latge, and O. Ibrahim-Granet Aspergillus fumigatus Induces Innate Immune Responses in Alveolar Macrophages through the MAPK Pathway Independently of TLR2 and TLR4 J. Immunol., September 15, 2006; 177(6): 3994 - 4001. [Abstract] [Full Text] [PDF]

				V. C. B. Bittencourt, R. T. Figueiredo, R. B. da Silva, D. S. Mourao-Sa, P. L. Fernandez, G. L. Sassaki, B. Mulloy, M. T. Bozza, and E. Barreto-Bergter An {alpha}-Glucan of Pseudallescheria boydii Is Involved in Fungal Phagocytosis and Toll-like Receptor Activation J. Biol. Chem., August 11, 2006; 281(32): 22614 - 22623. [Abstract] [Full Text] [PDF]

				Z. Jiang, P. Georgel, C. Li, J. Choe, K. Crozat, S. Rutschmann, X. Du, T. Bigby, S. Mudd, S. Sovath, et al. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis PNAS, July 18, 2006; 103(29): 10961 - 10966. [Abstract] [Full Text] [PDF]

				J. D. Turner, R. S. Langley, K. L. Johnston, G. Egerton, S. Wanji, and M. J. Taylor Wolbachia Endosymbiotic Bacteria of Brugia malayi Mediate Macrophage Tolerance to TLR- and CD40-Specific Stimuli in a MyD88/TLR2-Dependent Manner J. Immunol., July 15, 2006; 177(2): 1240 - 1249. [Abstract] [Full Text] [PDF]

				C. N. Renn, D. J. Sanchez, M. T. Ochoa, A. J. Legaspi, C.-K. Oh, P. T. Liu, S. R. Krutzik, P. A. Sieling, G. Cheng, and R. L. Modlin TLR Activation of Langerhans Cell-Like Dendritic Cells Triggers an Antiviral Immune Response J. Immunol., July 1, 2006; 177(1): 298 - 305. [Abstract] [Full Text] [PDF]

				N. D. Pecora, A. J. Gehring, D. H. Canaday, W. H. Boom, and C. V. Harding Mycobacterium tuberculosis LprA Is a Lipoprotein Agonist of TLR2 That Regulates Innate Immunity and APC Function J. Immunol., July 1, 2006; 177(1): 422 - 429. [Abstract] [Full Text] [PDF]

				S. Lehnardt, P. Henneke, E. Lien, D. L. Kasper, J. J. Volpe, I. Bechmann, R. Nitsch, J. R. Weber, D. T. Golenbock, and T. Vartanian A Mechanism for Neurodegeneration Induced by Group B Streptococci through Activation of the TLR2/MyD88 Pathway in Microglia J. Immunol., July 1, 2006; 177(1): 583 - 592. [Abstract] [Full Text] [PDF]

				P. Henneke and R. Berner Interaction of neonatal phagocytes with group B streptococcus: recognition and response. Infect. Immun., June 1, 2006; 74(6): 3085 - 3095. [Full Text] [PDF]

				A. E. Medvedev, I. Sabroe, J. D. Hasday, and S. N. Vogel Invited review: Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease Innate Immunity, June 1, 2006; 12(3): 133 - 150. [Abstract] [PDF]

				L. Romics Jr, G. Szabo, J. C. Coffey, J. H. Wang, and H. P. Redmond The Emerging Role of Toll-Like Receptor Pathways in Surgical Diseases Arch Surg, June 1, 2006; 141(6): 595 - 601. [Abstract] [Full Text] [PDF]

				P. Gray, A. Dunne, C. Brikos, C. A. Jefferies, S. L. Doyle, and L. A. J. O'Neill MyD88 Adapter-like (Mal) Is Phosphorylated by Bruton's Tyrosine Kinase during TLR2 and TLR4 Signal Transduction J. Biol. Chem., April 14, 2006; 281(15): 10489 - 10495. [Abstract] [Full Text] [PDF]

				C. H. Li, J. H. Wang, and H. P. Redmond Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation J. Leukoc. Biol., April 1, 2006; 79(4): 867 - 875. [Abstract] [Full Text] [PDF]

				M. Hashimoto, K. Tawaratsumida, H. Kariya, K. Aoyama, T. Tamura, and Y. Suda Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components Int. Immunol., February 1, 2006; 18(2): 355 - 362. [Abstract] [Full Text] [PDF]

				S. H. Han, J. H. Kim, H. S. Seo, M. H. Martin, G.-H. Chung, S. M. Michalek, and M. H. Nahm Lipoteichoic Acid-Induced Nitric Oxide Production Depends on the Activation of Platelet-Activating Factor Receptor and Jak2 J. Immunol., January 1, 2006; 176(1): 573 - 579. [Abstract] [Full Text] [PDF]

				T. Hubschle, J. Mutze, P. F. Muhlradt, S. Korte, R. Gerstberger, and J. Roth Pyrexia, anorexia, adipsia, and depressed motor activity in rats during systemic inflammation induced by the Toll-like receptors-2 and -6 agonists MALP-2 and FSL-1 Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R180 - R187. [Abstract] [Full Text] [PDF]

				S. Appel, V. Mirakaj, A. Bringmann, M. M. Weck, F. Grunebach, and P. Brossart PPAR-{gamma} agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-{kappa}B pathways Blood, December 1, 2005; 106(12): 3888 - 3894. [Abstract] [Full Text] [PDF]

				K. O. Omueti, J. M. Beyer, C. M. Johnson, E. A. Lyle, and R. I. Tapping Domain Exchange between Human Toll-like Receptors 1 and 6 Reveals a Region Required for Lipopeptide Discrimination J. Biol. Chem., November 4, 2005; 280(44): 36616 - 36625. [Abstract] [Full Text] [PDF]

				T. Shimizu, Y. Kida, and K. Kuwano A Dipalmitoylated Lipoprotein from Mycoplasma pneumoniae Activates NF-{kappa}B through TLR1, TLR2, and TLR6 J. Immunol., October 1, 2005; 175(7): 4641 - 4646. [Abstract] [Full Text] [PDF]

				B. C. Cole, H.-H. Mu, N. D. Pennock, A. Hasebe, F. V. Chan, L. R. Washburn, and M. R. Peltier Isolation and Partial Purification of Macrophage- and Dendritic Cell-Activating Components from Mycoplasma arthritidis: Association with Organism Virulence and Involvement with Toll-Like Receptor 2 Infect. Immun., September 1, 2005; 73(9): 6039 - 6047. [Abstract] [Full Text] [PDF]

				P. Georgel, K. Crozat, X. Lauth, E. Makrantonaki, H. Seltmann, S. Sovath, K. Hoebe, X. Du, S. Rutschmann, Z. Jiang, et al. A Toll-Like Receptor 2-Responsive Lipid Effector Pathway Protects Mammals against Skin Infections with Gram-Positive Bacteria Infect. Immun., August 1, 2005; 73(8): 4512 - 4521. [Abstract] [Full Text] [PDF]

				C. Feterowski, A. Novotny, S. Kaiser-Moore, P. F. Muhlradt, T. Rossmann-Bloeck, M. Rump, B. Holzmann, and H. Weighardt Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation Int. Immunol., August 1, 2005; 17(8): 1035 - 1046. [Abstract] [Full Text] [PDF]

				J. Qin, Y. Qian, J. Yao, C. Grace, and X. Li SIGIRR Inhibits Interleukin-1 Receptor- and Toll-like Receptor 4-mediated Signaling through Different Mechanisms J. Biol. Chem., July 1, 2005; 280(26): 25233 - 25241. [Abstract] [Full Text] [PDF]

				S. Borsutzky, K. Kretschmer, P. D. Becker, P. F. Muhlradt, C. J. Kirschning, S. Weiss, and C. A. Guzman The Mucosal Adjuvant Macrophage-Activating Lipopeptide-2 Directly Stimulates B Lymphocytes via the TLR2 without the Need of Accessory Cells J. Immunol., May 15, 2005; 174(10): 6308 - 6313. [Abstract] [Full Text] [PDF]

				C. S. Berenson, T. F. Murphy, C. T. Wrona, and S. Sethi Outer Membrane Protein P6 of Nontypeable Haemophilus influenzae Is a Potent and Selective Inducer of Human Macrophage Proinflammatory Cytokines Infect. Immun., May 1, 2005; 73(5): 2728 - 2735. [Abstract] [Full Text] [PDF]

				H. W. Chu, S. Jeyaseelan, J. G. Rino, D. R. Voelker, R. B. Wexler, K. Campbell, R. J. Harbeck, and R. J. Martin TLR2 Signaling Is Critical for Mycoplasma pneumoniae-Induced Airway Mucin Expression J. Immunol., May 1, 2005; 174(9): 5713 - 5719. [Abstract] [Full Text] [PDF]

				T. Abe, H. Hemmi, H. Miyamoto, K. Moriishi, S. Tamura, H. Takaku, S. Akira, and Y. Matsuura Involvement of the Toll-Like Receptor 9 Signaling Pathway in the Induction of Innate Immunity by Baculovirus J. Virol., March 1, 2005; 79(5): 2847 - 2858. [Abstract] [Full Text] [PDF]

				C. Habich, K. Kempe, R. van der Zee, R. Rumenapf, H. Akiyama, H. Kolb, and V. Burkart Heat Shock Protein 60: Specific Binding of Lipopolysaccharide J. Immunol., February 1, 2005; 174(3): 1298 - 1305. [Abstract] [Full Text] [PDF]

				N. Li, S. Choudhuri, N. J. Cherrington, and C. D. Klaassen DOWN-REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDE 4 (Oatp4; Oatp1b2; Slc21a10) mRNA BY LIPOPOLYSACCHARIDE THROUGH THE TOLL-LIKE RECEPTOR 4 (TLR4) Drug Metab. Dispos., November 1, 2004; 32(11): 1265 - 1271. [Abstract] [Full Text] [PDF]

				N. Sato, N. Takahashi, K. Suda, M. Nakamura, M. Yamaki, T. Ninomiya, Y. Kobayashi, H. Takada, K. Shibata, M. Yamamoto, et al. MyD88 But Not TRIF Is Essential for Osteoclastogenesis Induced by Lipopolysaccharide, Diacyl Lipopeptide, and IL-1{alpha} J. Exp. Med., September 7, 2004; 200(5): 601 - 611. [Abstract] [Full Text] [PDF]

				G. DiPerna, J. Stack, A. G. Bowie, A. Boyd, G. Kotwal, Z. Zhang, S. Arvikar, E. Latz, K. A. Fitzgerald, and W. L. Marshall Poxvirus Protein N1L Targets the I-{kappa}B Kinase Complex, Inhibits Signaling to NF-{kappa}B by the Tumor Necrosis Factor Superfamily of Receptors, and Inhibits NF-{kappa}B and IRF3 Signaling by Toll-like Receptors J. Biol. Chem., August 27, 2004; 279(35): 36570 - 36578. [Abstract] [Full Text] [PDF]

				E. Lorenz, D. C. Chemotti, K. Vandal, and P. A. Tessier Toll-Like Receptor 2 Represses Nonpilus Adhesin-Induced Signaling in Acute Infections with the Pseudomonas aeruginosa pilA Mutant Infect. Immun., August 1, 2004; 72(8): 4561 - 4569. [Abstract] [Full Text] [PDF]

				D. D. Bolz, R. S. Sundsbak, Y. Ma, S. Akira, C. J. Kirschning, J. F. Zachary, J. H. Weis, and J. J. Weis MyD88 Plays a Unique Role in Host Defense but Not Arthritis Development in Lyme Disease J. Immunol., August 1, 2004; 173(3): 2003 - 2010. [Abstract] [Full Text] [PDF]

				R. Malley, S. C. Morse, L. C. C. Leite, A. P. M. Areas, P. L. Ho, F. S. Kubrusly, I. C. Almeida, and P. Anderson Multiserotype Protection of Mice against Pneumococcal Colonization of the Nasopharynx and Middle Ear by Killed Nonencapsulated Cells Given Intranasally with a Nontoxic Adjuvant Infect. Immun., July 1, 2004; 72(7): 4290 - 4292. [Abstract] [Full Text] [PDF]

				J. Y. Lee, L. Zhao, H. S. Youn, A. R. Weatherill, R. Tapping, L. Feng, W. H. Lee, K. A. Fitzgerald, and D. H. Hwang Saturated Fatty Acid Activates but Polyunsaturated Fatty Acid Inhibits Toll-like Receptor 2 Dimerized with Toll-like Receptor 6 or 1 J. Biol. Chem., April 23, 2004; 279(17): 16971 - 16979. [Abstract] [Full Text] [PDF]

				Z. Jiang, T. W. Mak, G. Sen, and X. Li Toll-like receptor 3-mediated activation of NF-{kappa}B and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-{beta} PNAS, March 9, 2004; 101(10): 3533 - 3538. [Abstract] [Full Text] [PDF]

				T. Okusawa, M. Fujita, J.-i. Nakamura, T. Into, M. Yasuda, A. Yoshimura, Y. Hara, A. Hasebe, D. T. Golenbock, M. Morita, et al. Relationship between Structures and Biological Activities of Mycoplasmal Diacylated Lipopeptides and Their Recognition by Toll-Like Receptors 2 and 6 Infect. Immun., March 1, 2004; 72(3): 1657 - 1665. [Abstract] [Full Text] [PDF]

				C Schneider, T Schmidt, C Ziske, K Tiemann, K-M Lee, V Uhlinsky, P Behrens, T Sauerbruch, I G H Schmidt-Wolf, P F Muhlradt, et al. Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model Gut, March 1, 2004; 53(3): 355 - 361. [Abstract] [Full Text] [PDF]

				M. A. Campos, M. Closel, E. P. Valente, J. E. Cardoso, S. Akira, J. I. Alvarez-Leite, C. Ropert, and R. T. Gazzinelli Impaired Production of Proinflammatory Cytokines and Host Resistance to Acute Infection with Trypanosoma cruzi in Mice Lacking Functional Myeloid Differentiation Factor 88 J. Immunol., February 1, 2004; 172(3): 1711 - 1718. [Abstract] [Full Text] [PDF]

				S. Akira Toll-like Receptor Signaling J. Biol. Chem., October 3, 2003; 278(40): 38105 - 38108. [Full Text] [PDF]

				K. Saito, T. Yajima, H. Nishimura, K. Aiba, R. Ishimitsu, T. Matsuguchi, T. Fushimi, Y. Ohshima, Y. Tsukamoto, and Y. Yoshikai Soluble Branched {beta}-(1,4)Glucans from Acetobacter Species Show Strong Activities to Induce Interleukin-12 in Vitro and Inhibit T-helper 2 Cellular Response with Immunoglobulin E Production in Vivo J. Biol. Chem., October 3, 2003; 278(40): 38571 - 38578. [Abstract] [Full Text] [PDF]

				M. Fujita, T. Into, M. Yasuda, T. Okusawa, S. Hamahira, Y. Kuroki, A. Eto, T. Nisizawa, M. Morita, and K.-i. Shibata Involvement of Leucine Residues at Positions 107, 112, and 115 in a Leucine-Rich Repeat Motif of Human Toll-Like Receptor 2 in the Recognition of Diacylated Lipoproteins and Lipopeptides and Staphylococcus aureus Peptidoglycans J. Immunol., October 1, 2003; 171(7): 3675 - 3683. [Abstract] [Full Text] [PDF]

				F. Hayashi, T. K. Means, and A. D. Luster Toll-like receptors stimulate human neutrophil function Blood, October 1, 2003; 102(7): 2660 - 2669. [Abstract] [Full Text] [PDF]

				J. Y. Lee, J. Ye, Z. Gao, H. S. Youn, W. H. Lee, L. Zhao, N. Sizemore, and D. H. Hwang Reciprocal Modulation of Toll-like Receptor-4 Signaling Pathways Involving MyD88 and Phosphatidylinositol 3-Kinase/AKT by Saturated and Polyunsaturated Fatty Acids J. Biol. Chem., September 26, 2003; 278(39): 37041 - 37051. [Abstract] [Full Text] [PDF]

				M. Matsumoto, K. Funami, M. Tanabe, H. Oshiumi, M. Shingai, Y. Seto, A. Yamamoto, and T. Seya Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells J. Immunol., September 15, 2003; 171(6): 3154 - 3162. [Abstract] [Full Text] [PDF]

				K. A. Marr, S. Arunmozhi Balajee, T. R. Hawn, A. Ozinsky, U. Pham, S. Akira, A. Aderem, and W. Conrad Liles Differential Role of MyD88 in Macrophage-Mediated Responses to Opportunistic Fungal Pathogens Infect. Immun., September 1, 2003; 71(9): 5280 - 5286. [Abstract] [Full Text] [PDF]

				U. Deiters, M. Gumenscheimer, C. Galanos, and P. F. Muhlradt Toll-Like Receptor 2- and 6-Mediated Stimulation by Macrophage-Activating Lipopeptide 2 Induces Lipopolysaccharide (LPS) Cross Tolerance in Mice, Which Results in Protection from Tumor Necrosis Factor Alpha but in Only Partial Protection from Lethal LPS Doses Infect. Immun., August 1, 2003; 71(8): 4456 - 4462. [Abstract] [Full Text] [PDF]

				E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF]

				G. Fenhalls, G. R. Squires, L. Stevens-Muller, J. Bezuidenhout, G. Amphlett, K. Duncan, and P. T. Lukey Associations between Toll-Like Receptors and Interleukin-4 in the Lungs of Patients with Tuberculosis Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 28 - 38. [Abstract] [Full Text] [PDF]

				M. Muroi, T. Ohnishi, S. Azumi-Mayuzumi, and K.-i. Tanamoto Lipopolysaccharide-Mimetic Activities of a Toll-Like Receptor 2-Stimulatory Substance(s) in Enterobacterial Lipopolysaccharide Preparations Infect. Immun., June 1, 2003; 71(6): 3221 - 3226. [Abstract] [Full Text] [PDF]

				Z. Jiang, M. Zamanian-Daryoush, H. Nie, A. M. Silva, B. R. G. Williams, and X. Li Poly(dI{middle dot}dC)-induced Toll-like Receptor 3 (TLR3)-mediated Activation of NFkappa B and MAP Kinase Is through an Interleukin-1 Receptor-associated Kinase (IRAK)-independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR J. Biol. Chem., May 2, 2003; 278(19): 16713 - 16719. [Abstract] [Full Text] [PDF]

				J. L. Curtis and A. Punturieri Enhancing Antitumor Immunity Perioperatively: A Matter of Timing, Cooperation, and Specificity Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 541 - 545. [Full Text] [PDF]

				K. Shingu, C. Kruschinski, A. Luhrmann, K. Grote, T. Tschernig, S. von Horsten, and R. Pabst Intratracheal Macrophage-Activating Lipopeptide-2 Reduces Metastasis in the Rat Lung Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 316 - 321. [Abstract] [Full Text] [PDF]

				J.-Y. Choe, B. Crain, S. R. Wu, and M. Corr Interleukin 1 Receptor Dependence of Serum Transferred Arthritis Can be Circumvented by Toll-like Receptor 4 Signaling J. Exp. Med., February 17, 2003; 197(4): 537 - 542. [Abstract] [Full Text] [PDF]

				M. T. Harte, I. R. Haga, G. Maloney, P. Gray, P. C. Reading, N. W. Bartlett, G. L. Smith, A. Bowie, and L. A.J. O'Neill The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense J. Exp. Med., February 3, 2003; 197(3): 343 - 351. [Abstract] [Full Text] [PDF]

				T. Morichika, H. K. Takahashi, H. Iwagaki, T. Yoshino, R. Tamura, M. Yokoyama, S. Mori, T. Akagi, M. Nishibori, and N. Tanaka Histamine Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-{alpha} Production in an Intercellular Adhesion Molecule-1- and B7.1-Dependent Manner J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 624 - 633. [Abstract] [Full Text] [PDF]

				M. Yamamoto, S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-{beta} Promoter in the Toll-Like Receptor Signaling J. Immunol., December 15, 2002; 169(12): 6668 - 6672. [Abstract] [Full Text] [PDF]

				K. Takeda, O. Takeuchi, and S. Akira Recognition of lipopeptides by Toll-like receptors Innate Immunity, December 1, 2002; 8(6): 459 - 463. [Abstract] [PDF]

				T. Liu, T. Matsuguchi, N. Tsuboi, T. Yajima, and Y. Yoshikai Differences in Expression of Toll-Like Receptors and Their Reactivities in Dendritic Cells in BALB/c and C57BL/6 Mice Infect. Immun., December 1, 2002; 70(12): 6638 - 6645. [Abstract] [Full Text] [PDF]

				D. Schilling, K. Thomas, K. Nixdorff, S. N. Vogel, and M. J. Fenton Toll-Like Receptor 4 and Toll-IL-1 Receptor Domain-Containing Adapter Protein (TIRAP)/Myeloid Differentiation Protein 88 Adapter-Like (Mal) Contribute to Maximal IL-6 Expression in Macrophages J. Immunol., November 15, 2002; 169(10): 5874 - 5880. [Abstract] [Full Text] [PDF]

				T. Ogawa, Y. Asai, M. Hashimoto, O. Takeuchi, T. Kurita, Y. Yoshikai, K. Miyake, and S. Akira Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway Int. Immunol., November 1, 2002; 14(11): 1325 - 1332. [Abstract] [Full Text] [PDF]

				A. E. Medvedev, A. Lentschat, L. M. Wahl, D. T. Golenbock, and S. N. Vogel Dysregulation of LPS-Induced Toll-Like Receptor 4-MyD88 Complex Formation and IL-1 Receptor-Associated Kinase 1 Activation in Endotoxin-Tolerant Cells J. Immunol., November 1, 2002; 169(9): 5209 - 5216. [Abstract] [Full Text] [PDF]

				E. Kopp and R. Medzhitov A Plague on Host Defense J. Exp. Med., October 21, 2002; 196(8): 1009 - 1012. [Full Text] [PDF]

				H. Takada, S. Yokoyama, and Shuhua Yang Mini-review: Enhancement of endotoxin activity by muramyldipeptide Innate Immunity, October 1, 2002; 8(5): 337 - 342. [Abstract] [PDF]

				K. Hoshino, T. Kaisho, T. Iwabe, O. Takeuchi, and S. Akira Differential involvement of IFN-{beta} in Toll-like receptor-stimulated dendritic cell activation Int. Immunol., October 1, 2002; 14(10): 1225 - 1231. [Abstract] [Full Text] [PDF]

				P. Henneke, O. Takeuchi, R. Malley, E. Lien, R. R. Ingalls, M. W. Freeman, T. Mayadas, V. Nizet, S. Akira, D. L. Kasper, et al. Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways J. Immunol., October 1, 2002; 169(7): 3970 - 3977. [Abstract] [Full Text] [PDF]

				J. H. Wang, M. Doyle, B. J. Manning, Q. Di Wu, S. Blankson, and H. P. Redmond Induction of Bacterial Lipoprotein Tolerance Is Associated with Suppression of Toll-like Receptor 2 Expression J. Biol. Chem., September 20, 2002; 277(39): 36068 - 36075. [Abstract] [Full Text] [PDF]

				T. H. Flo, L. Ryan, E. Latz, O. Takeuchi, B. G. Monks, E. Lien, O. Halaas, S. Akira, G. Skjak-Brak, D. T. Golenbock, et al. Involvement of Toll-like Receptor (TLR) 2 and TLR4 in Cell Activation by Mannuronic Acid Polymers J. Biol. Chem., September 13, 2002; 277(38): 35489 - 35495. [Abstract] [Full Text] [PDF]

				S. A. Leigh and K. S. Wise Identification and Functional Mapping of the Mycoplasma fermentans P29 Adhesin Infect. Immun., September 1, 2002; 70(9): 4925 - 4935. [Abstract] [Full Text] [PDF]

				T. Into, M. Fujita, T. Okusawa, A. Hasebe, M. Morita, and K.-I. Shibata Synergic Effects of Mycoplasmal Lipopeptides and Extracellular ATP on Activation of Macrophages Infect. Immun., July 1, 2002; 70(7): 3586 - 3591. [Abstract] [Full Text] [PDF]

				A. Luhrmann, U. Deiters, J. Skokowa, M. Hanke, J. E. Gessner, P. F. Muhlradt, R. Pabst, and T. Tschernig In Vivo Effects of a Synthetic 2-Kilodalton Macrophage-Activating Lipopeptide of Mycoplasma fermentans after Pulmonary Application Infect. Immun., July 1, 2002; 70(7): 3785 - 3792. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takeuchi, O. Articles by Akira, S. Search for Related Content PubMed PubMed Citation Articles by Takeuchi, O. Articles by Akira, S.